Zimmermann Investment Management & Planning LLC Abb Vie Inc. Transaction History

Zimmermann Investment Management & Planning LLC

$287 Million
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 22, 2024	SELL	$137.6 - $154.97 $1,100 - $1,239	-8 Reduced 0.55%	1,444 $223,000
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $59,046 - $68,355	-442 Reduced 23.34%	1,452 $216,000
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $143,905 - $179,081	-1,086 Reduced 36.44%	1,894 $255,000
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $175,990 - $202,679	-1,217 Reduced 29.0%	2,980 $474,000
Q4 2022 Jan 20, 2023	BUY	$138.31 - $165.87 $25,863 - $31,017	187 Added 4.66%	4,197 $0
Q3 2022 Nov 01, 2022	BUY	$134.21 - $153.93 $538,182 - $617,259	4,010 New	4,010 $538,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zimmermann Investment Management & Planning LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zimmermann Investment Management & Planning LLC with notifications on news.

Account